Safe Orthopaedics publishes its results for the first half of 2020 with an improvement of 20% in the operating income

• Contraction of sales for the first half of 2020: -15%
• Improvement of the Recurring Operating Income of +20%
• Operational integration of LCI Medical within the Group

Eragny-sur-Oise, France, September 28th, 2020, 18h30 CEST – Safe Orthopaedics (FR0013467123 - ALSAF), a company specializing in the design and marketing of ready-to-use technologies for spinal surgeries, delivering the safest treatment for spinal fractures urgently treated, today announces its results for the first half of 2020 to June 30.

Safe Orthopaedics’ half-year financial report will be available by September 30^th in the Investors > Documentation section of the Company’s website (www.SafeOrthopaedics.com).

In thousands of euros –IFRS	30/06/2020	30/06/2019
Revenues – Direct sales	882	1 010
Revenues – Indirect sales	843	1 033
Adjusted total revenues	1 725	2 043
Other income	3	92
Purchases used and changes in inventories	(1 211)	(1 433)
External costs	(939)	(2 203)
Personnel costs	(2 413)	(2 205)
Other operating expenses	(357)	(314)
Operating income / (loss) before non-recurring items	(3 191)	(4 021)
Other operating income (expenses)	0	9
Operating income / (loss)	(3 191)	(4 011)
Financial income / (loss)	(352)	(100)
Net income / (loss)	(3 543)	(4 111)

In the first half of 2020, revenues recorded a decrease of only 15%, 1 725k€, compared to the first semester of 2019, despite the worldwide sanitary lockdown that occurred during the first semester. Indirect sales were the most affected with a decrease of only -18%.